Portia

DRUG2 trials

Sponsors

Oregon Health and Science University, ViiV Healthcare

Conditions

Body WeightContraceptive UsageHIV Infections

Phase 1

Effect of GSK3640254 on the Pharmacokinetics of a Combination Oral Contraceptive

CompletedNCT03984825

ViiV HealthcareHIV Infections

Start: 2019-06-13End: 2019-08-16Updated: 2020-08-27

Phase 4

Oral Contraceptives and Body Mass Index

CompletedNCT01170390

Oregon Health and Science UniversityBody Weight, Contraceptive Usage

Start: 2009-09-30End: 2011-12-31Updated: 2015-12-31